These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16597366

  • 1. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
    Kanai Y, Hara T, Imai A.
    J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
    [Abstract] [Full Text] [Related]

  • 2. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats.
    Kanai Y, Nakazato E, Fujiuchi A, Hara T, Imai A.
    Neuropharmacology; 2005 Dec; 49(7):977-84. PubMed ID: 15998524
    [Abstract] [Full Text] [Related]

  • 3. Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.
    Rigoni M, Trevisani M, Gazzieri D, Nadaletto R, Tognetto M, Creminon C, Davis JB, Campi B, Amadesi S, Geppetti P, Harrison S.
    Br J Pharmacol; 2003 Mar; 138(5):977-85. PubMed ID: 12642400
    [Abstract] [Full Text] [Related]

  • 4. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
    Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, Clark N, Boyce S, Kerby J, Ali Z, Chou M, Middleton R, Kaczorowski G, Jones AB.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
    [Abstract] [Full Text] [Related]

  • 5. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR, Pan HL.
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [Abstract] [Full Text] [Related]

  • 6. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis.
    Wick EC, Hoge SG, Grahn SW, Kim E, Divino LA, Grady EF, Bunnett NW, Kirkwood KS.
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G959-69. PubMed ID: 16399878
    [Abstract] [Full Text] [Related]

  • 7. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
    McDonald HA, Neelands TR, Kort M, Han P, Vos MH, Faltynek CR, Moreland RB, Puttfarcken PS.
    Eur J Pharmacol; 2008 Oct 31; 596(1-3):62-9. PubMed ID: 18755179
    [Abstract] [Full Text] [Related]

  • 8. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS, Neelands TR, Bianchi BR, McGaraughty S, El Kouhen R, Han P, Chu KL, McDonald HA, Vos M, Niforatos W, Bayburt EK, Gomtsyan A, Lee CH, Honore P, Sullivan JP, Jarvis MF, Faltynek CR.
    J Pharmacol Exp Ther; 2008 Sep 31; 326(3):879-88. PubMed ID: 18515644
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord.
    Wardle KA, Ranson J, Sanger GJ.
    Br J Pharmacol; 1997 Jul 31; 121(5):1012-6. PubMed ID: 9222561
    [Abstract] [Full Text] [Related]

  • 10. Effect of resiniferatoxin on glutamatergic spontaneous excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord.
    Jiang CY, Fujita T, Yue HY, Piao LH, Liu T, Nakatsuka T, Kumamoto E.
    Neuroscience; 2009 Dec 29; 164(4):1833-44. PubMed ID: 19778582
    [Abstract] [Full Text] [Related]

  • 11. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
    Zhou HY, Chen SR, Chen H, Pan HL.
    J Pharmacol Exp Ther; 2008 Nov 29; 327(2):375-82. PubMed ID: 18669865
    [Abstract] [Full Text] [Related]

  • 12. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
    Shimizu I, Iida T, Horiuchi N, Caterina MJ.
    J Pharmacol Exp Ther; 2005 Sep 29; 314(3):1378-85. PubMed ID: 15947039
    [Abstract] [Full Text] [Related]

  • 13. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist.
    Gevaert T, Vandepitte J, Hutchings G, Vriens J, Nilius B, De Ridder D.
    Neurourol Urodyn; 2007 Sep 29; 26(3):440-50; discussion 451-3. PubMed ID: 17266134
    [Abstract] [Full Text] [Related]

  • 14. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.
    Heng YJ, Saunders CI, Kunde DA, Geraghty DP.
    Regul Pept; 2011 Apr 11; 167(2-3):250-8. PubMed ID: 21329730
    [Abstract] [Full Text] [Related]

  • 15. Cloning and pharmacological characterization of mouse TRPV1.
    Correll CC, Phelps PT, Anthes JC, Umland S, Greenfeder S.
    Neurosci Lett; 2004 Nov 03; 370(1):55-60. PubMed ID: 15489017
    [Abstract] [Full Text] [Related]

  • 16. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU, De Man JG, Ruyssers NE, Deiteren A, Van Nassauw L, Timmermans JP, Martinet W, Herman AG, Pelckmans PA, De Winter BY.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan 03; 294(1):G245-53. PubMed ID: 17991707
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
    Watabiki T, Kiso T, Kuramochi T, Yonezawa K, Tsuji N, Kohara A, Kakimoto S, Aoki T, Matsuoka N.
    J Pharmacol Exp Ther; 2011 Mar 03; 336(3):743-50. PubMed ID: 21098091
    [Abstract] [Full Text] [Related]

  • 18. Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors.
    de Man JG, Boeckx S, Anguille S, de Winter BY, de Schepper HU, Herman AG, Pelckmans PA.
    Neurogastroenterol Motil; 2008 May 03; 20(5):546-56. PubMed ID: 18194153
    [Abstract] [Full Text] [Related]

  • 19. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG, Tamir R, Deng H, Klionsky L, Kuang R, Le A, Lee D, Louis JC, Magal E, Manning BH, Rubino J, Surapaneni S, Tamayo N, Wang T, Wang J, Wang J, Wang W, Youngblood B, Zhang M, Zhu D, Norman MH, Gavva NR.
    J Pharmacol Exp Ther; 2008 Jul 03; 326(1):218-29. PubMed ID: 18420600
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat.
    Jakab B, Helyes Z, Varga A, Bölcskei K, Szabó A, Sándor K, Elekes K, Börzsei R, Keszthelyi D, Pintér E, Petho G, Németh J, Szolcsányi J.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):35-44. PubMed ID: 15978575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.